Furusyo N et al. |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori. |
1999 |
Intern. Med. |
pmid:10526942
|
Chérin P et al. |
Macrophagic myofasciitis: improvement with antibiotic therapy. |
1999 |
J. Rheumatol. |
pmid:10529163
|
Moola S et al. |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. |
1999 |
Chest |
pmid:10531162
|
Gonzalez Cueto D et al. |
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection]. |
1999 |
Acta Gastroenterol. Latinoam. |
pmid:10533659
|
Saito H et al. |
[Chemoprophylaxis against Mycobacterium avium complex infection induced in mice]. |
1999 |
Kekkaku |
pmid:10535281
|
Gisbert JP et al. |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10540045
|
Hammett DC and Evans MF |
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat? |
1999 |
Can Fam Physician |
pmid:10540692
|
Sassa K et al. |
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543765
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Unal M et al. |
Ocular toxicity of intravitreal clarithromycin. |
1999 |
Retina (Philadelphia, Pa.) |
pmid:10546942
|
Woo PC et al. |
Antibiotics modulate vaccine-induced humoral immune response. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548572
|
Adamsson I et al. |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552979
|
Cirioni O et al. |
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552982
|
Yoshida Y et al. |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560737
|
Valencia IC et al. |
Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells. |
1999 |
Int. J. Dermatol. |
pmid:10561050
|
MartÃn de Argila C and Boixeda D |
[A ration proposal for the eradicating treatment of Helicobacter pylori infection]. |
1999 |
Med Clin (Barc) |
pmid:10562929
|
Adeyemi EO et al. |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10563537
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Fattorini L et al. |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. |
1999 |
Microb. Drug Resist. |
pmid:10566874
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|